• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心房颤动的发病率、类型及卒中危险因素:一项基于人群的队列研究。

Incidence, type of atrial fibrillation and risk factors for stroke: a population-based cohort study.

作者信息

Johansson Cecilia, Dahlqvist Erik, Andersson Jonas, Jansson Jan-Håkan, Johansson Lars

机构信息

Department of Public Health and Clinical Medicine, Skellefteå Research Unit, Umeå University, Umeå, Västerbotten, Sweden.

出版信息

Clin Epidemiol. 2017 Jan 24;9:53-62. doi: 10.2147/CLEP.S122916. eCollection 2017.

DOI:10.2147/CLEP.S122916
PMID:28182159
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5283072/
Abstract

PURPOSE

The aims of this study were to estimate the incidence of atrial fibrillation and atrial flutter (AF), to assess the presence of provoking factors and risk factors for stroke and systemic embolism, and to determine the type of AF in patients with first-diagnosed AF.

PATIENTS AND METHODS

This cohort study was performed in northern Sweden between January 1, 2011 and December 31, 2012. Diagnosis registries were searched for the International Classification of Diseases-10 code for AF (I48) to identify cases of incident AF. All AF diagnoses were electrocardiogram-verified. Data pertaining to provoking factors, type of AF and presence of risk factors for stroke and systemic embolism according to the CHADS-VASc score were obtained from medical records.

RESULTS

The incidence of AF in the entire population was 4.0 per 1,000 person-years. The incidence was 27.5 per 1,000 person-years in patients aged ≥80 years. A total of 21% of all patients had a provoking factor in association with the first-diagnosed episode of AF. The CHADS-VASc score was 2 or higher in 81% of the patients. Permanent AF was the most common type of AF (29%).

CONCLUSION

There was a considerable increase in the incidence of AF with age, and a provoking factor was found in one-fifth. The most common type of AF was permanent AF. Four in five patients had a CHADS-VASc score of 2 or more.

摘要

目的

本研究旨在估计心房颤动和心房扑动(房颤)的发病率,评估诱发因素以及中风和全身性栓塞的危险因素的存在情况,并确定首次诊断为房颤的患者的房颤类型。

患者与方法

这项队列研究于2011年1月1日至2012年12月31日在瑞典北部进行。通过搜索诊断登记处,查找房颤的国际疾病分类-10代码(I48)以识别新发房颤病例。所有房颤诊断均经心电图证实。从病历中获取与诱发因素、房颤类型以及根据CHADS-VASc评分得出的中风和全身性栓塞危险因素的存在情况相关的数据。

结果

整个人群中房颤的发病率为每1000人年4.0例。80岁及以上患者的发病率为每1000人年27.5例。所有患者中共有21%在首次诊断为房颤的发作时有诱发因素。81%的患者CHADS-VASc评分为2分或更高。永久性房颤是最常见的房颤类型(29%)。

结论

房颤的发病率随年龄显著增加,五分之一的患者存在诱发因素。最常见的房颤类型是永久性房颤。五分之四的患者CHADS-VASc评分为2分或更高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f3c/5283072/b8fd3a735d8e/clep-9-053Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f3c/5283072/bdb8af37df41/clep-9-053Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f3c/5283072/b8fd3a735d8e/clep-9-053Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f3c/5283072/bdb8af37df41/clep-9-053Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f3c/5283072/b8fd3a735d8e/clep-9-053Fig2.jpg

相似文献

1
Incidence, type of atrial fibrillation and risk factors for stroke: a population-based cohort study.心房颤动的发病率、类型及卒中危险因素:一项基于人群的队列研究。
Clin Epidemiol. 2017 Jan 24;9:53-62. doi: 10.2147/CLEP.S122916. eCollection 2017.
2
Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.评估 CHA2DS2-VASc 评分在伴有和不伴有心房颤动的心力衰竭患者中预测缺血性卒、血栓栓塞和死亡的价值。
JAMA. 2015 Sep 8;314(10):1030-8. doi: 10.1001/jama.2015.10725.
3
Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.肾功能障碍、卒中风险评分(CHADS2、CHA2DS2-VASc 和 R2CHADS2)与心房颤动导管消融术后血栓栓塞事件风险:莱比锡心脏中心房颤消融登记研究。
Circ Arrhythm Electrophysiol. 2013 Oct;6(5):868-74. doi: 10.1161/CIRCEP.113.000869. Epub 2013 Sep 18.
4
CHA2DS2-VASc score is directly associated with the risk of pulmonary embolism in patients with atrial fibrillation.CHA2DS2-VASc 评分与房颤患者的肺栓塞风险直接相关。
Am J Med. 2014 Jan;127(1):45-52. doi: 10.1016/j.amjmed.2013.10.004. Epub 2013 Oct 15.
5
Stroke prediction with CHADS-VASc score in patients with mesenteric ischemia without atrial fibrillation-insights from a nationwide cohort.无房颤的肠系膜缺血患者中CHADS-VASc评分对卒中的预测——来自一项全国性队列研究的见解
J Clin Neurosci. 2017 Nov;45:193-198. doi: 10.1016/j.jocn.2017.06.007. Epub 2017 Jul 3.
6
CHADS-VASc Score (Congestive Heart Failure, Hypertension, Age ≥75 [Doubled], Diabetes Mellitus, Prior Stroke or Transient Ischemic Attack [Doubled], Vascular Disease, Age 65-74, Female) for Stroke in Asian Patients With Atrial Fibrillation: A Korean Nationwide Sample Cohort Study.亚洲房颤患者卒中的CHADS-VASc评分(充血性心力衰竭、高血压、年龄≥75岁[加倍]、糖尿病、既往卒中或短暂性脑缺血发作[加倍]、血管疾病、年龄65 - 74岁、女性):一项韩国全国性样本队列研究。
Stroke. 2017 Jun;48(6):1524-1530. doi: 10.1161/STROKEAHA.117.016926. Epub 2017 Apr 28.
7
The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.CHA2DS2-VASc 评分在 CHADS2 评分为 0-1 的房颤患者中对卒中风险分层的价值:一项全国性队列研究。
Thromb Haemost. 2012 Jun;107(6):1172-9. doi: 10.1160/TH12-03-0175. Epub 2012 Apr 3.
8
CHA2DS2-VASc score for ischaemic stroke risk stratification in patients with chronic obstructive pulmonary disease with and without atrial fibrillation: a nationwide cohort study.CHA2DS2-VASc 评分用于伴或不伴心房颤动的慢性阻塞性肺疾病患者的缺血性脑卒中风险分层:一项全国性队列研究。
Europace. 2018 Apr 1;20(4):575-581. doi: 10.1093/europace/eux065.
9
[The thromboembolism risk of low-risk atrial fibrillation patients with different clinical characteristics].[不同临床特征的低风险心房颤动患者的血栓栓塞风险]
Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Sep 24;48(9):735-739. doi: 10.3760/cma.j.cn112148-20200306-00164.
10
CHA2DS2-VASc score for prediction of ischemic stroke in patients with systemic lupus erythematosus without atrial fibrillation.用于预测无房颤的系统性红斑狼疮患者缺血性卒中的CHA2DS2-VASc评分
Lupus. 2018 Jul;27(8):1240-1246. doi: 10.1177/0961203318763535. Epub 2018 Mar 19.

引用本文的文献

1
Normal Blood Pressure, High Normal Blood Pressure, and Risk of Incident Atrial Fibrillation: A Population-Based Cohort Study.正常血压、正常高值血压与房颤发病风险:一项基于人群的队列研究
Health Sci Rep. 2025 Jul 9;8(7):e71002. doi: 10.1002/hsr2.71002. eCollection 2025 Jul.
2
Incidence, Outcomes and Risk Factors for Atrial Fibrillation in Patients With JAK2-Positive Myeloproliferative Neoplasms.JAK2 阳性骨髓增殖性肿瘤患者心房颤动的发病率、转归及危险因素
Cancer Med. 2025 Jul;14(13):e71015. doi: 10.1002/cam4.71015.
3
Temporal trends in mortality and causes of death in patients with incident atrial fibrillation: a nationwide register study from 2010 to 2018.

本文引用的文献

1
Long-term outcomes of secondary atrial fibrillation in the community: the Framingham Heart Study.社区中继发性心房颤动的长期结局:弗雷明汉心脏研究
Circulation. 2015 May 12;131(19):1648-55. doi: 10.1161/CIRCULATIONAHA.114.014058. Epub 2015 Mar 13.
2
Prospective national study of the prevalence, incidence, management and outcome of a large contemporary cohort of patients with incident non-valvular atrial fibrillation.对大量当代新发非瓣膜性心房颤动患者队列的患病率、发病率、管理及结局进行的前瞻性全国性研究。
J Am Heart Assoc. 2015 Jan 21;4(1):e001486. doi: 10.1161/JAHA.114.001486.
3
Characterization of patients with atrial fibrillation not treated with oral anticoagulants.
2010 年至 2018 年期间,新发心房颤动患者的死亡率和死因的时间趋势:一项全国范围内的登记研究。
BMJ Open. 2024 Sep 13;14(9):e080836. doi: 10.1136/bmjopen-2023-080836.
4
RR Interval-based Atrial Fibrillation Detection using Traditional and Ensemble Machine Learning Algorithms.基于RR间期的心房颤动检测:使用传统和集成机器学习算法
J Med Signals Sens. 2023 Jul 12;13(3):224-232. doi: 10.4103/jmss.jmss_4_22. eCollection 2023 Jul-Sep.
5
The EAT-Lancet diet, genetic susceptibility and risk of atrial fibrillation in a population-based cohort.基于人群的队列研究中,EAT-柳叶刀饮食、遗传易感性与心房颤动风险的关系。
BMC Med. 2023 Jul 28;21(1):280. doi: 10.1186/s12916-023-02985-6.
6
Comprehensive nationwide incidence and prevalence trends of atrial fibrillation in Finland.芬兰心房颤动的全面全国发病率和患病率趋势。
Open Heart. 2022 Nov;9(2). doi: 10.1136/openhrt-2022-002140.
7
I is constitutively active via PKC epsilon in aging mediated atrial fibrillation.在衰老介导的心房颤动中,I通过蛋白激酶Cε持续激活。
iScience. 2022 Oct 25;25(11):105442. doi: 10.1016/j.isci.2022.105442. eCollection 2022 Nov 18.
8
Machine learning prediction of atrial fibrillation in cardiovascular patients using cardiac magnetic resonance and electronic health information.利用心脏磁共振成像和电子健康信息对心血管疾病患者的房颤进行机器学习预测。
Front Cardiovasc Med. 2022 Sep 28;9:998558. doi: 10.3389/fcvm.2022.998558. eCollection 2022.
9
Hub microRNAs and genes in the development of atrial fibrillation identified by weighted gene co-expression network analysis.通过加权基因共表达网络分析鉴定心房颤动发生发展中的枢纽 microRNAs 和基因。
BMC Med Genomics. 2021 Nov 15;14(1):271. doi: 10.1186/s12920-021-01124-5.
10
World Heart Federation Roadmap on Atrial Fibrillation - A 2020 Update.世界心脏联盟心房颤动路线图-2020 年更新版。
Glob Heart. 2021 May 27;16(1):41. doi: 10.5334/gh.1023.
未接受口服抗凝剂治疗的房颤患者的特征描述。
Scand J Prim Health Care. 2014 Dec;32(4):226-31. doi: 10.3109/02813432.2014.984952. Epub 2014 Dec 3.
4
Estimating the prevalence of atrial fibrillation in a general population using validated electronic health data.利用经过验证的电子健康数据估算普通人群中心房颤动的患病率。
Clin Epidemiol. 2013 Dec 9;5:475-81. doi: 10.2147/CLEP.S53420. eCollection 2013.
5
A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry.一项在欧洲心脏病学会成员国中进行的关于心房颤动管理的前瞻性调查:EURObservational Research Programme Atrial Fibrillation(EORP-AF)试点综合登记处的基线结果。
Europace. 2014 Mar;16(3):308-19. doi: 10.1093/europace/eut373. Epub 2013 Dec 17.
6
Risk scoring and thromboprophylactic treatment of patients with atrial fibrillation with and without access to primary healthcare data: experience from the Stockholm health care system.有和无初级医疗保健数据的房颤患者的风险评分和血栓预防治疗:斯德哥尔摩医疗保健系统的经验。
Int J Cardiol. 2013 Dec 10;170(2):208-14. doi: 10.1016/j.ijcard.2013.10.063. Epub 2013 Oct 26.
7
Atrial fibrillation prevalence revisited.心房颤动患病率再探讨。
J Intern Med. 2013 Nov;274(5):461-8. doi: 10.1111/joim.12114. Epub 2013 Aug 7.
8
Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry.新诊断为有卒中风险的房颤患者的风险概况和抗血栓治疗:来自国际、观察性、前瞻性 GARFIELD 注册研究的观点。
PLoS One. 2013 May 21;8(5):e63479. doi: 10.1371/journal.pone.0063479. Print 2013.
9
Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients.房颤的发病率和患病率:基于 830 万患者的分析。
Europace. 2013 Apr;15(4):486-93. doi: 10.1093/europace/eus333. Epub 2012 Dec 6.
10
2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association.《2012年欧洲心脏病学会心房颤动管理指南重点更新:2010年欧洲心脏病学会心房颤动管理指南更新——由欧洲心律协会特别贡献制定》
Europace. 2012 Oct;14(10):1385-413. doi: 10.1093/europace/eus305. Epub 2012 Aug 24.